These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11499106)

  • 1. Retrospective validation of a surveillance system for unexplained illness and death: New Haven County, Connecticut.
    Kluger MD; Sofair AN; Heye CJ; Meek JI; Sodhi RK; Hadler JL
    Am J Public Health; 2001 Aug; 91(8):1214-9. PubMed ID: 11499106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexplained deaths and critical illnesses of suspected infectious cause, Taiwan, 2000-2005.
    Wang TH; Wei KC; Jiang DD; Chiu CH; Chang SC; Wang JD
    Emerg Infect Dis; 2008 Oct; 14(10):1653-5. PubMed ID: 18826839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998.
    Hajjeh RA; Relman D; Cieslak PR; Sofair AN; Passaro D; Flood J; Johnson J; Hacker JK; Shieh WJ; Hendry RM; Nikkari S; Ladd-Wilson S; Hadler J; Rainbow J; Tappero JW; Woods CW; Conn L; Reagan S; Zaki S; Perkins BA
    Emerg Infect Dis; 2002 Feb; 8(2):145-53. PubMed ID: 11897065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explaining the unexplained: identifying infectious causes of critical illness and death in Minnesota.
    DeVries A; Lees C; Rainbow J; Lynfield R
    Minn Med; 2008 Nov; 91(11):34-6. PubMed ID: 19108543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of infectious disease occurrences in the community: an analysis of symptom presentation in the emergency department.
    Suyama J; Sztajnkrycer M; Lindsell C; Otten EJ; Daniels JM; Kressel AB
    Acad Emerg Med; 2003 Jul; 10(7):753-63. PubMed ID: 12837650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting of vancomycin-resistant enterococci in Connecticut: implementation and validation of a state-based surveillance system.
    Dembek ZF; Kellerman SE; Ganley L; Capacchione CM; Tenover FC; Cartter ML; Van Kruiningen HJ; Jarvis WR; Hadler JL
    Infect Control Hosp Epidemiol; 1999 Oct; 20(10):671-5. PubMed ID: 10530644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence of infectious diseases estimated by the surveillance data in 2002-2004 in Japan].
    Hashimoto S
    Nihon Koshu Eisei Zasshi; 2006 Oct; 53(10):794-9. PubMed ID: 17144573
    [No Abstract]   [Full Text] [Related]  

  • 9. Active and passive surveillance for communicable diseases in child care facilities, Seattle-King County, Washington.
    MacDonald JK; Boase J; Stewart LK; Alexander ER; Solomon SL; Cordell RL
    Am J Public Health; 1997 Dec; 87(12):1951-5. PubMed ID: 9431282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplained deaths in Connecticut, 2002-2003: failure to consider category a bioterrorism agents in differential diagnoses.
    Palumbo JP; Meek JI; Fazio DM; Turner SB; Hadler JL; Sofair AN
    Disaster Med Public Health Prep; 2008 Jun; 2(2):87-94. PubMed ID: 18525371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study.
    Iwashyna TJ; Hodgson CL; Pilcher D; Bailey M; van Lint A; Chavan S; Bellomo R
    Lancet Respir Med; 2016 Jul; 4(7):566-573. PubMed ID: 27155770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of electronic surveillance tool for acute kidney injury: A retrospective analysis.
    Ahmed A; Vairavan S; Akhoundi A; Wilson G; Chiofolo C; Chbat N; Cartin-Ceba R; Li G; Kashani K
    J Crit Care; 2015 Oct; 30(5):988-93. PubMed ID: 26070247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of unexplained illness and death.
    Pugliese G; Favero MS
    Infect Control Hosp Epidemiol; 1998 Apr; 19(4):285-6. PubMed ID: 9605280
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Death Records to Augment Notifiable Conditions Reporting in Washington State.
    Oltean HN; DeBolt CA; Goldoft MJ; Lofy KH
    J Public Health Manag Pract; 2016; 22(3):283-9. PubMed ID: 25764369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communicable disease mortality: now you see it, now you don't.
    Plaut RR; Silvi JJ
    J Public Health Policy; 1991; 12(4):464-74. PubMed ID: 1802890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of hospital records in four African countries, 1975-1990, with emphasis on infectious diseases.
    Petit PL; van Ginneken JK
    J Trop Med Hyg; 1995 Aug; 98(4):217-27. PubMed ID: 7636917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The causes of hospital admission and death among children in Bamako, Mali.
    Campbell JD; Sow SO; Levine MM; Kotloff KL
    J Trop Pediatr; 2004 Jun; 50(3):158-63. PubMed ID: 15233192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood asthma surveillance using computerized billing records: a pilot study.
    Morris RD; Naumova EN; Goldring J; Hersch M; Munasinghe RL; Anderson H
    Public Health Rep; 1997; 112(6):506-12. PubMed ID: 10822479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of cancer incidence in Connecticut counties and towns, 1989-91.
    Polednak AP; Flannery JT
    Conn Med; 1995 Jun; 59(6):323-30. PubMed ID: 7648850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying the burden of chronic viral hepatitis-related cirrhosis hospitalizations in New Haven County, Connecticut.
    Durante AJ; Meek JI; St Louis T; Navarro VJ; Sofair AN
    Conn Med; 2008 Aug; 72(7):393-7. PubMed ID: 18763666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.